Corcept Therapeutics(CORT-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Corcept Therapeutics

101 REDWOOD SHORES PARKWAY
REDWOOD CITY CA 94065 USA
P: 650-327-3270
http://www.corcept.com

Profile

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.

Key Executives

NameTitle
Joseph K. BelanoffCEO/Co-Founder/Director/President
G. Charles RobbOther Executive Officer/Secretary
Atabak MokariCFO/Treasurer
Sean MaduckPresident, Divisional
Joseph Douglas LyonChief Accounting Officer/Chief Technology Officer
Hazel HuntChief Scientific Officer
William GuyerOther Executive Officer

More from The Globe

Nuclear ambitions are stirring again, and could turn this stock around
Atkins Realis headquarters are seen in Montreal on Wednesday, Sept. 24, 2025. THE CANADIAN PRESS/Christinne Muschi
The highest-yielding stocks on the TSX, plus risk data
Un homme passe devant un immeuble de Toronto qui abritait autrefois la Bourse de Toronto, le jeudi 18 août 2011. LA PRESSE CANADIENNE/Aaron Vincent Elkaim
Outgoing Telus CEO presents sunny view of his tenure, despite stock price challenges
Darren Entwistle, CEO of Telus, visits The Globe and Mail offices for an editorial board interview. June 19, 2026 (Sarah Espedido/The Globe and Mail)
the mover
Why this multi-billion-dollar money manager believes emerging markets are poised for outperformance
Rohit Khuller, vice-president of investment management at Montreal-based Letko, Brosseau & Associates Inc. Illustration by Joel Kimmel
Small caps to watch: Aecon buys back interest in utilities business, how much Jamieson Wellness could go for in a takeout, and a warning from Sherritt
FILE PHOTO: People walk through the Canary Wharf financial district of London, Britain, December 7, 2018. REUTERS/Simon Dawson
Thursday’s Insider Report: Multiple executives sell shares in this stock that’s doubled in 2026
Technicians put the final touches on the second of three Radarsat Constellation Mission satellites at the MDA facility Thursday, June 21, 2018 in Montreal.
Dye & Durham dumps CEO, Tyler Proud now leads company through board committee
The Bay Street financial district of Toronto is shown on Sunday Sept. 8, 2024. THE CANADIAN PRESS/Doug Ives
Six bargain stock picks from hedge fund managers
forex candlestick charts monitored

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.